Louis Chrystal 4
4 · TScan Therapeutics, Inc. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
Louis Chrystal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-03+400,000→ 400,000 totalExercise: $3.06Exp: 2035-01-03→ Voting Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.